Author

Constantine Mutata

Observed name: Mutata Constantine

Institution: University of Zimbabwe

Observed institutions: University of Zimbabwe, Midlands State University

ORCID: 0000-0003-1006-0544

Observed ORCID: 0000-0003-1006-0544

OpenAlex ID: A5086448467

Cost-effectiveness of single, high-dose, liposomal amphotericin regimen for HIV-associated cryptococcal meningitis in five countries in sub-Saharan Africa: an economic analysis of the AMBITION-cm trial

2022 · David S Lawrence, Charles Muthoga, et al. · The Lancet Global Health · 34

Effectiveness and safety of shortened intensive treatment for children with tuberculous meningitis (SURE): a protocol for a phase 3 randomised controlled trial evaluating 6 months of antituberculosis therapy and 8 weeks of aspirin in Asian and African children with tuberculous meningitis

2025 · Julie Huynh, Chishala Chabala, et al. · BMJ Open · 16

Evaluation of the adverse events following immunization surveillance system in Guruve District, Mashonaland Central 2017

2018 · Mutata Constantine, Tshuma Cremance, et al. · Pan African Medical Journal · 16

Twice-Daily Dosing of Dolutegravir in Infants on Rifampicin Treatment: A Pharmacokinetic Substudy of the EMPIRICAL Trial

2023 · Tom G Jacobs, Vivian Mumbiro, et al. · Clinical Infectious Diseases · 12

Paternal factors affecting under-five immunization status in Sub-Saharan Africa: A systematic review and meta-analysis

2025 · Godfrey Musuka, Enos Moyo, et al. · Vaccine · 8

BREATHER Plus clinical trial design: A randomised non-inferiority trial evaluating the efficacy, safety and acceptability of short cycle (five days on, two days off) dolutegravir/tenofovir-based triple antiretroviral therapy (ART) compared to daily ART in virologically suppressed adolescents living with HIV aged 12 to <20 years in sub-Saharan Africa

2025 · Fredrick Katongole, Tiyara Arumugam, et al. · Contemporary Clinical Trials · 6

Oral step-down, optimal drug, and total duration of antibiotic treatment in African children hospitalised with severe community-acquired pneumonia (PediCAP): a factorial randomised controlled trial

2026 · Julia A Bielicki, Michelle Clements, et al. · The Lancet · 5

Gender-Associated Factors on the Occurrence and Prevalence of Zero-Dose Children in Sub-Saharan Africa: A Critical Literature Review

2025 · Godfrey Musuka, Enos Moyo, et al. · Tropical Medicine and Infectious Disease · 4

Trial design and enrolment characteristics of LATA (Long-Acting Treatment in Adolescents): A randomised, open-label, non-inferiority, 96-week trial evaluating the virological efficacy, safety, acceptability and quality-of-life of the dual long-acting injectable regimen cabotegravir/ rilpivirine compared to daily oral therapy in virologically suppressed adolescents with HIV-1 infection, aged 12 to <20 years, in Sub-Saharan Africa

2026 · Diana Anena, Elizabeth Chappell, et al. · Contemporary Clinical Trials · 2

Population Pharmacokinetics of Dolutegravir in African Children: Results From the CHAPAS-4 Trial

2024 · Hylke Waalewijn, Roeland E Wasmann, et al. · Journal of the Pediatric Infectious Diseases Society · 2

Switch to injectable cabotegravir–rilpivirine given every 8 weeks in adolescents living with HIV with virological suppression in sub-Saharan Africa (LATA): a randomised, open-label, multicentre, 96-week non-inferiority trial

2026 · Mutsa Bwakura-Dangarembizi, Elizabeth Chappell, et al. · The Lancet

Empirical treatment with valganciclovir in infants living with HIV and hospitalised with severe pneumonia in Africa: a multicentre, open-label, factorial, randomised, controlled, superiority trial

2026 · Cinta Moraleda, Alfredo Tagarro, et al. · The Lancet

Efficacy and safety of short-cycle, dolutegravir-based antiretroviral therapy in adolescents living with HIV (BREATHER Plus): a multicentre, open-label, randomised, parallel, two-arm, non-inferiority trial

2026 · Adeodata R Kekitiinwa, Angus Jennings, et al. · The Lancet HIV

Short Intensified Anti-Tuberculosis Therapy and Adjunctive Aspirin in Children and Adolescents with Tuberculous Meningitis: A Factorial, Randomised, Partially Blinded, Phase 3 Trial

2026 · Julie Huynh, Suzanne T. Anderson, et al. · SSRN Electronic Journal

Works count: 14

Citation count: 105

H-index: 6

I10-index: 4